Since in cases of non-mutated JAK2V617F, CALR and myeloproliferative leukemia (MPL), according to the 2016 World Health Organization diagnostic criteria, the diagnosis of ET is still based on the absence of reactive thrombocytosis (Arber et al., 2016). This evidence concerns the gene CALR and essential thrombocythemia.